April 6, 2023
Discriminatory Health Metrics, Inclusive VA Healthcare
Neal Masia, Health Economist and Columbia University Professor of Business and Economics, discusses how the QALY discriminates against rare and chronic disease patients and calls for a more patient-focused health technology assessment; the Jax Act,...
Neal Masia, Health Economist and Columbia University Professor of Business and Economics, discusses how the QALY discriminates against rare and chronic disease patients and calls for a more patient-focused health technology assessment; the Jax Act, named after Jax Scott, an Army Special Operations Warrant Officer, helps female veterans who served in cultural support teams in Afghanistan access healthcare through the VA; and MacKay Jimeson, the Executive Director of Patients Rising’s Patient Access and Affordability Project, explains the challenge of getting CMS to cover drugs approved through the FDA’s accelerated approval process.
Patients Rising Now letter to the House E&C Committee
Neal Masia
Co-Founder and CEO, Entity Risk
Adjunct Professor of Economics and Management, Columbia University
Listen On
